Evidence map›Paper›PMID 41185632›Full record

ArticleCellular and molecular bioengineering2025

Correction: Developing Nanoparticle-Based Therapeutics for Targeting the Microenvironment in Obesity-Induced Endometrial Cancer.

Laura D Paredes Cuatin, David Zhang, Federico Zertuche, Linda Mota, Caleb Dang, Bijaya Nayak, Li-Ling Lin, Eric M Brey, Achraf Noureddine, Nameer B Kirma and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular and molecular bioengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Laura D Paredes CuatinDepartment of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, AET 1.328, 1 UTSA Circle, San Antonio, TX 78249 USA.
David ZhangDepartment of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, AET 1.328, 1 UTSA Circle, San Antonio, TX 78249 USA.
Federico ZertucheDepartment of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, AET 1.328, 1 UTSA Circle, San Antonio, TX 78249 USA.
Linda MotaDepartment of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, AET 1.328, 1 UTSA Circle, San Antonio, TX 78249 USA.
Caleb DangDepartment of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM USA.
Bijaya NayakDepartment of Molecular Medicine, University of Texas Health San Antonio, 8403 Floyd Curl Drive, San Antonio, TX 78248 USA.
Li-Ling LinDepartment of Molecular Medicine, University of Texas Health San Antonio, 8403 Floyd Curl Drive, San Antonio, TX 78248 USA.
Eric M BreyDepartment of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, AET 1.328, 1 UTSA Circle, San Antonio, TX 78249 USA.
Achraf NoureddineDepartment of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM USA.
Nameer B KirmaDepartment of Molecular Medicine, University of Texas Health San Antonio, 8403 Floyd Curl Drive, San Antonio, TX 78248 USA.
Maria A Gonzalez PorrasDepartment of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, AET 1.328, 1 UTSA Circle, San Antonio, TX 78249 USA.ORCID 0000-0001-6594-8802

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1007/s12195-025-00853-2.].

Identifiers

PMID41185632
PMCPMC12579603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.